>
Switch to:

Instil Bio Price-to-Tangible-Book

: 3.72 (As of Today)
View and export this data going back to 2021. Start your Free Trial

As of today (2021-10-17), Instil Bio's share price is $17.92. Instil Bio's Tangible Book per Share of Jun. 2021 for the quarter that ended in Jun. 2021 was $4.81. Hence, Instil Bio's Price to Tangible Book Ratio of today is 3.72.

The historical rank and industry rank for Instil Bio's Price-to-Tangible-Book or its related term are showing as below:

NAS:TIL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.72   Med: 4.49   Max: 4.97
Current: 3.73

3.72
4.97

During the past 2 years, Instil Bio's highest Price to Tangible Book Ratio was 4.97. The lowest was 3.72. And the median was 4.49.

NAS:TIL's Price-to-Tangible-Book is ranked lower than
99.99% of the 250 Companies
in the Biotechnology industry.

( Industry Median: 4.88 vs. NAS:TIL: 3.73 )

A closely related ratio is called PB Ratio. As of today, Instil Bio's share price is $17.92. Instil Bio's Book Value per Sharefor the quarter that ended in Jun. 2021 was $4.94. Hence, Instil Bio's P/B Ratio of today is 3.63.


Instil Bio Price-to-Tangible-Book Historical Data

The historical data trend for Instil Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instil Bio Annual Data
Trend Dec19 Dec20
Price-to-Tangible-Book
- -

Instil Bio Quarterly Data
Dec19 Mar20 Jun20 Dec20 Mar21 Jun21
Price-to-Tangible-Book Premium Member Only - - - 4.97 4.01

Competitive Comparison

For the Biotechnology subindustry, Instil Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Instil Bio Price-to-Tangible-Book Distribution

For the Biotechnology industry and Healthcare sector, Instil Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Instil Bio's Price-to-Tangible-Book falls into.



Instil Bio Price-to-Tangible-Book Calculation

Instil Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2021 )
=17.92/4.813
=3.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Instil Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Instil Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Instil Bio Business Description

Instil Bio logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
3963 Maple Avenue, Suite 350, Dallas, TX, USA, 75219
Instil Bio Inc is a clinical-stage cell therapy company. It is developing tumor infiltrating lymphocytes for the treatment of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)